UK Markets closed

Rite Aid Corporation (RAD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.86+0.09 (+1.41%)
As of 01:47PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.76
Open6.73
Bid6.86 x 1400
Ask6.87 x 1800
Day's range6.57 - 6.91
52-week range4.68 - 19.22
Volume1,174,738
Avg. volume4,652,728
Market cap382.312M
Beta (5Y monthly)1.00
PE ratio (TTM)N/A
EPS (TTM)-3.12
Earnings date13 Apr 2022 - 18 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date14 Oct 1999
1y target est3.00
  • Motley Fool

    Zoom Video Communications: Bull vs. Bear

    Why Rite Aid's (NYSE: RAD) stock pop and raised guidance still aren't enough to get him interested in buying shares. Additionally, with shares down nearly 70% over the past year, is Zoom Video Communications (NASDAQ: ZM) a screaming buy or past its prime? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.

  • Yahoo Finance Video

    Walgreens earnings top estimates, sales drop 4.2%

    Yahoo Finance Live anchors discuss third-quarter earnings for Walgreens.

  • Business Wire

    Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members

    PHILADELPHIA, June 30, 2022--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.